NAOV logo

NanoVibronix (NAOV)

Profile

Full Name

NanoVibronix, Inc.

Ticker Symbol

NAOV

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

May 28, 2015

Indexes

Not included

Website

http://www.nanovibronix.com

Employees

31

Key Details

Price

$7.26(-4.47%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.56M(+12.05% YoY)

Annual EPS

-$151.03(+41.12% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.26
NAOV price is $7.26

30-Day Relative Volume

0.70
NAOV 30-day relative volume is 0.70

Price Performance

Price Today change

-4.47%
NAOV price is down -4.47% today

Price YTD change

+11.86%
NAOV price is up +11.86% since January 1st

Price 1-year change

-14.4%
NAOV price is down -14.4% year-on-year

Price 3-year change

-95.73%
NAOV price is down -95.73% over the past 3 years

Price Range

Price All-time high

$1870.00
NAOV price is currently -99.61% below its historical high of $1870.00

Price 3-year low

$1.92
NAOV price is currently +278.13% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$5.51M
NAOV market capitalization is $5.51 million

Market cap 3-year change

-74.54%
NAOV market capitalization is down -74.54% over the past 3 years

Market cap All-time high

$81.26M
NAOV market capitalization is currently -93.22% below its historical high of $81.26 million

Market cap sector rank

14.31%
NAOV market capitalization is higher than 14.31% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+200%
NAOV shares outstanding is up +200% year-on-year

Shares Outstanding 3-Year Change

+496.47%
NAOV shares outstanding is up +496.47% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.13
NAOV beta is -0.13

200-day SMA

$6.18
NAOV price is currently +17.47% above its 200-day simple moving average

50-day SMA

$4.27
NAOV price is currently +70.15% above its 50-day simple moving average

RSI

69.33
NAOV 14-day relative strength index is 69.33

Volume

0.70
NAOV 30-day relative volume is 0.70

ATR

$1.64
NAOV average true range is $1.64

10-day Historical Volatility

746.88%
NAOV 10-day historical volatility is 746.88%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.56M
NAOV annual revenue is $2.56 million

Revenue Analysts estimate

-
NAOV annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+12.05%
NAOV annual revenue is up +12.05% year-on-year

Revenue Sector rank

16.98%
NAOV annual revenue is higher than 16.98% of companies in Healthcare sector

EPS

EPS

-$151.03
NAOV annual earnings per share is -$151.03

EPS Analysts estimate

-
NAOV annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+41.12%
NAOV annual earnings per share is up +41.12% year-on-year

EPS Sector rank

1.41%
NAOV annual earnings per share is higher than 1.41% of companies in Healthcare sector

Profit

Gross profit

$1.51M
NAOV annual gross profit is $1.51 million

Gross margin

58.95%
NAOV annual gross profit margin is 58.95%

Operating profit

-$3.58M
NAOV annual operating income is -$3.58 million

Operating margin

-140.03%
NAOV annual operating profit margin is -140.03%

Net income

-$3.71M
NAOV annual net profit is -$3.71 million

Net margin

-144.84%
NAOV annual net profit margin is -144.84%

Expenses

Total expenses

$6.14M
NAOV annual total expenses is $6.14 million

Operating expenses

$5.09M
NAOV annual total operating expenses is $5.09 million

Cost of goods sold

$1.05M
NAOV annual cost of goods sold is $1.05 million

Selling, general & administrative expenses

$4.18M
NAOV annual SGA is $4.18 million

Depreciation and amortization

$1000.00
NAOV annual depreciation & amortization is $1000.00

Interest expense

$135.00K
NAOV annual interest expense is $135.00 thousand

Income tax

$19.00K
NAOV annual income tax is $19.00 thousand

EBIT & EBITDA

EBIT

-$3.55M
NAOV annual earnings before interest & taxes is -$3.55 million

EBITDA

-$3.55M
NAOV annual EBITDA is -$3.55 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.63M
NAOV annual total assets is $3.63 million

Non current assets

$298.00K
NAOV annual long term assets is $298.00 thousand

Current assets

$3.33M
NAOV annual total current assets is $3.33 million

Cash and cash equivalents

$752.00K
NAOV annual cash & cash equivalents is $752.00 thousand

Accounts receivable

$98.00K
NAOV annual accounts receivable is $98.00 thousand

Inventory

$2.19M
NAOV annual inventory is $2.19 million

Liabilities

Total liabilities

$3.00M
NAOV annual total liabilities is $3.00 million

Long term liabilities

$280.00K
NAOV annual total long term liabilities is $280.00 thousand

Current liabilities

$2.72M
NAOV annual total current liabilities is $2.72 million

Accounts payable

$47.00K
NAOV annual accounts payable is $47.00 thousand

Debt

Total debt

$116.00K
NAOV annual total debt is $116.00 thousand

Total debt 1-year change

+2220%
NAOV annual total debt is up +2220% year-on-year

Long term debt

$64.00K
NAOV annual long term debt is $64.00 thousand

Short term debt

$52.00K
NAOV annual short term debt is $52.00 thousand

Equity & Capital

Shareholders equity

$627.00K
NAOV annual stockholders equity is $627.00 thousand

Book value

$627.00K
NAOV annual book value is $627.00 thousand

Retained earnings

-$69.80M
NAOV annual retained earnings is -$69.80 million

Working capital

$609.00K
NAOV annual working capital is $609.00 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$2.52M
NAOV annual cash flow from operations is -$2.52 million

Cash from operations 1-year change

+30.15%
NAOV annual cash flow from operations is up +30.15% year-on-year

Cash from investing

-$3000.00
NAOV annual cash flow from investing activities is -$3000.00

Cash from investing 1-year change

-200%
NAOV annual cash flow from investing activities is down -200% year-on-year

Cash from financing

$1000.00
NAOV annual cash flow from financing activities is $1000.00

Cash from financing 1-year change

-99.98%
NAOV annual cash flow from financing activities is down -99.98% year-on-year

CAPEX

CAPEX

$3000.00
NAOV annual capital expenditures is $3000.00

CAPEX 1-year change

+200%
NAOV annual capital expenditures is up +200% year-on-year

Free Cash Flow

Free cash flow

-$2.52M
NAOV annual free cash flow is -$2.52 million

Free cash flow 1-year change

+30.09%
NAOV annual free cash flow is up +30.09% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

58.95%
NAOV annual gross profit margin is 58.95%

Operating margin

-140.03%
NAOV annual operating profit margin is -140.03%

Net margin

-144.84%
NAOV annual net profit margin is -144.84%

ROA & ROE

ROA

-71.92%
NAOV annual return on assets is -71.92%

ROE

-160.56%
NAOV annual return on equity is -160.56%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NAOV price to earnings ratio value is unknown

PE ratio Sector rank

-
NAOV price to earnings ratio is unknown

PB Ratio

PB ratio

8.79
NAOV price to book ratio is 8.79

PB ratio Sector rank

91.11%
NAOV price to book ratio is higher than 91.11% of companies in Healthcare sector

PS Ratio

PS ratio

2.16
NAOV price to sales ratio is 2.16

PS ratio Sector rank

44.87%
NAOV price to sales ratio is higher than 44.87% of companies in Healthcare sector

Enterprise value

Enterprise value

$4.88M
NAOV enterprise value is $4.88 million

Enterprise value Sector rank

19.27%
NAOV enterprise value is higher than 19.27% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.37
NAOV EV/EBITDA is -1.37

EV/EBITDA Sector rank

37.86%
NAOV EV/EBITDA is higher than 37.86% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.22
NAOV annual current ratio is 1.22

Quick ratio

0.42
NAOV annual quick ratio is 0.42

Leverage

Debt to equity

0.00
NAOV annual debt to equity ratio is 0.00

Interest coverage ratio

-26.30
NAOV annual interest coverage ratio is -26.30

Risk & Stability

Piotroski F-Score

3
NAOV piotroski f-score is 3

Altman Z-Score

-28.15
NAOV altman z-score is -28.15

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

NLSP logo
NLS Pharmaceutics AG (NLSP)
WORK Medical Technology Group LTD (WOK)
TNON logo
Tenon Medical (TNON)
MOVE logo
Movano (MOVE)
NKGN logo
NKGen Biotech (NKGN)
APM logo
Aptorum Group Limited (APM)
LYRA logo
Lyra Therapeutics (LYRA)
PTN logo
Palatin Technologies (PTN)
SPRB logo
Spruce Biosciences (SPRB)
  • What is the ticker symbol for NanoVibronix?
  • Does NanoVibronix pay dividends?
  • What sector is NanoVibronix in?
  • What industry is NanoVibronix in?
  • What country is NanoVibronix based in?
  • When did NanoVibronix go public?
  • Is NanoVibronix in the S&P 500?
  • Is NanoVibronix in the NASDAQ 100?
  • Is NanoVibronix in the Dow Jones?
  • When was NanoVibronix's last earnings report?
  • When does NanoVibronix report earnings?
  • Should I buy NanoVibronix stock now?

What is the ticker symbol for NanoVibronix?

The ticker symbol for NanoVibronix is NASDAQ:NAOV

Does NanoVibronix pay dividends?

No, NanoVibronix does not pay dividends

What sector is NanoVibronix in?

NanoVibronix is in the Healthcare sector

What industry is NanoVibronix in?

NanoVibronix is in the Medical Devices industry

What country is NanoVibronix based in?

NanoVibronix is headquartered in United States

When did NanoVibronix go public?

NanoVibronix's initial public offering (IPO) was on May 28, 2015

Is NanoVibronix in the S&P 500?

No, NanoVibronix is not included in the S&P 500 index

Is NanoVibronix in the NASDAQ 100?

No, NanoVibronix is not included in the NASDAQ 100 index

Is NanoVibronix in the Dow Jones?

No, NanoVibronix is not included in the Dow Jones index

When was NanoVibronix's last earnings report?

NanoVibronix's most recent earnings report was on Nov 14, 2024

When does NanoVibronix report earnings?

The next expected earnings date for NanoVibronix is May 15, 2025

Should I buy NanoVibronix stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page